INDUCTION OF A CYTOTOXIC T LYMPHOCYTE (CTL) RESPONSE TO PLASMID DNA DELIVERED VIA LIPODINE™ LIPOSOMES*

REFERENCES

• Gregoriadis G., Saffie R., de Souza J.B. Liposome-Mediated DNA Vaccination. FEBS Lett. 1997; 402(2–3)107–110
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Genetic Vaccines: Strategies for Optimization. Pharmaceutical Research 1998; 15: 661–670
   PubMed Web of Science ®Google Scholar
• Perrie Y., Gregoriadis G. Liposome-Entrapped Plasmid DNA: Characterisation Studies. Biochim. Biophys. Acta 2000; 1475(2)125–132
   PubMedGoogle Scholar
• Chattergoon M., Boyer J., Weiner D.B. Genetic Immunization: A New Era in Vaccines and Immune Therapeutics. FASEB J. 1997; 11(10)753–763
   PubMed Web of Science ®Google Scholar
• Davis H.L., Whalen R.G., Demeneix B.A. Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression. Hum. Gene Ther. 1993; 4(2)151–159
   PubMedGoogle Scholar
• Swain W.E., Heydenburg Fuller D., Wu M.S., Barr L.J., Fuller J.T., Culp J., Burkholder J., Dixon R.M., Widera G., Vessey R., Roy M.J. Tolerability and Immune Responses in Humans to a PowderJect DNA Vaccine for Hepatitis B. Dev. Biol. (Basel) 2000; 104: 115–119
   PubMedGoogle Scholar
• Perrie Y., Frederik P.M., Gregoriadis G. Liposome-Mediated DNA Vaccination: The Effect of Vesicle Composition. Vaccine 2001; 19(23–24)3301–3310
   PubMed Web of Science ®Google Scholar
• Tumer A., Kirby C., Senior J., Gregoriadis G. Fate of Cholesterol-Rich Liposomes after Subcutaneous Injection into Rats. Biochim. Biophys. Acta 1983; 760(1)119–125
   PubMedGoogle Scholar
• Velinova M., Read N., Kirby C., Gregoriadis G. Morphological Observations on the Fate of Liposomes in the Regional Lymph Nodes after Footpad Injection into Rats. Biochim. Biophys. Acta 1996; 1299(2)207–215
   PubMed Web of Science ®Google Scholar
• Yoshida A., Nagata T., Uchijima M., Higashi T., Koide Y. Advantage of Gene Gun-Mediated Over Intramuscular Inoculation of Plasmid DNA Vaccine in Reproducible Induction of Specific Immune Responses. Vaccine 2000; 18: 1725–1729
   PubMed Web of Science ®Google Scholar
• Lipford G.B., Hoffman M., Wagner H., Heeg K. Primary in vivo Responses to Ovalbumin. Probing the Predictive Value of the Kb Binding Motif. J. Immunol. 1993; 150(4)1212–1222
   PubMedGoogle Scholar
• Schirmbeck R., Wild J., Reimann J. Similar as well as Distinct MHC Class I-Binding Peptides are Generated by Exogenous and Endogenous Processing of Hepatitis B Virus Surface Antigen. Eur. J. Immunol. 1998; 28(12)4149–4161
   PubMedGoogle Scholar
• Gregoriadis G., Saffie R., Hart S.L. High Yield Incorporation of Plasmid DNA Within Liposomes: Effect on DNA Integrity and Transfection Efficiency. J. Drug Targeting 1996; 3(6)467–475
   Google Scholar
• Kirby C., Gregoriadis G. Dehydration-Rehydration Vesicles (DRV): A New Method for High Yield Drug Entrapment in Liposomes. Biotechnology 1994; 2: 979–984
   Google Scholar
• Simmons C.P., Mastroeni P., Fowler R., Ghaem-maghami M., Lycke N., Pizza M., Rappuoli R., Dougan G. MHC Class I-Restricted Cytotoxic Lymphocyte Responses Induced by Enterotoxin-Based Mucosal Adjuvants. J. Immunol. 1999; 163(12)6502–6510
   PubMed Web of Science ®Google Scholar
• Gorer P.A. Studies in Antibody Response of Mice to Tumor Inoculation. Br. J. Cancer 1950; 4: 372
   PubMed Web of Science ®Google Scholar
• Korzeniewski C., Callewaert D.M. An Enzyme-Release Assay for Natural Cytotoxicity. J. Immunol. Meth. 1983; 64: 313
   PubMed Web of Science ®Google Scholar
• Decker T., Lohmann-Matthes M.L. A Quick and Simple Method for the Quantitation of Lactate Dehydrogenase Release in Measurements of Cellular Cytotoxicity and Tumor Necrosis Factor (TNF) Activity. J. Immunol. Meth. 1988; 115: 61
   PubMed Web of Science ®Google Scholar
• Eisenbraun M.D., Fuller D.H., Haynes J.R. Examination of Parameters Affecting the Elicitation of Humoral Immune Responses by Particle Bombardment-Mediated Genetic Immunization. DNA Cell Biol. 1993; 12(9)791–797
   PubMedGoogle Scholar
• Lai W.C., Bennett M., Johnston S.A., Barry M.A., Pakes S.P. Protection Against Mycoplasma Pulmonis Infection by Genetic Vaccination. DNA Cell Biol. 1995; 14(7)643–651
   PubMedGoogle Scholar
• Price B.M., Liner A.L., Park S., Leppla S.H., Mateczun A., Galloway D.R. Protection Against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor Protein. Infect. Immun. 2001; 7: 4509–4515
   Google Scholar
• Perrie Y., Obrenovic M., McCarthy D., Gregoriadis G. Proceedings of the British Pharmaceutical Conference, GlasgowUK, Sept, 23–262001, 53
   Google Scholar
• Lewis P.J., Babiuk L.A. DNA Vaccines: A Review. Advances in Virus Research 1999; 54: 129–188
   PubMed Web of Science ®Google Scholar
• Davies D.H., Stauss H.J. The Significance of Human Leukocyte Antigen Associations with Cervical Cancer. Papillomavirus Report 1997; 8(2)43–50
   Google Scholar